Janus Kinase Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RIGL | F | Rigel Pharmaceuticals, Inc. | 2.63 | |
GLPG | F | Galapagos NV | -0.29 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 1.24 | |
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 0.22 | |
IBB | D | iShares Nasdaq Biotechnology Index Fund | 0.16 | |
IBBQ | C | Invesco Nasdaq Biotechnology ETF | 0.06 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.05 |
Compare ETFs
Related Industries:
Biotechnology
- Janus Kinase
Janus kinase (JAK) is a family of intracellular, nonreceptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. They were initially named "just another kinase" 1 and 2 (since they were just two of a large number of discoveries in a PCR-based screen of kinases), but were ultimately published as "Janus kinase". The name is taken from the two-faced Roman god of beginnings, endings and duality, Janus, because the JAKs possess two near-identical phosphate-transferring domains. One domain exhibits the kinase activity, while the other negatively regulates the kinase activity of the first.
Recent Comments
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
From the Blog
Featured Articles